BioLight Reports Positive Clinical Study Findings for Dry Eye Syndrome

Israel’s BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced the completion of a U.S. More...

BioLight and Integra Join in XL Vision Treating Eye Diseases

BioLight and Integra will invest one million dollars in a new firm which will develop drugs for the treatment of eye diseases. Together they will own a 40% stake in X.L. Vision. Technology, designed to improve More...

Biolight jumps on strong Zacks recommendation

– Zacks cites the company for its technology, products, and meeting its targets.     The share of Bio-Light Israeli Life Sciences Investments Ltd. (TASE:BOLT; Bulletin Board: BLGTY) shot More...